Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCRIT for Anemia of CKD in Long Term Care
NCT00337935Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 2006
- Primary completion
- Jul 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 2 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Johnson & Johnson. Started Jul 2006; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00337935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337935.